V VestedGrant
investing

Loss Aversion and Equity Concentration: The Hold-to-Breakeven Trap

Loss aversion makes selling below your mental cost basis feel catastrophic, even when the rational choice is to sell and diversify. The cost compounds the longer you hold.

By VestedGrant Editorial · Reviewed by Helena Borgstrom Pemberton, PhD Behavioral Economics · 6 min read · Updated April 21, 2026

Kahneman and Tversky’s 1979 prospect theory paper established that the psychological impact of a loss is approximately twice the impact of an equivalent gain. A $1,000 loss feels like a $2,000-equivalent gain in its pull on decision-making. This asymmetry drives one of the most destructive patterns in equity compensation: the decision to hold a declining concentrated position until it returns to a mental breakeven point that may never come.

The employee bought or received stock at $180. The stock now trades at $135. Selling at $135 “realizes the loss.” Holding means the loss is “just on paper.” The thinking feels sophisticated: why realize a loss when you can wait for the stock to recover? It is not sophisticated. It is loss aversion dressed as patience, and it costs tech employees hundreds of thousands of dollars per concentrated position, per year of delay.

This article walks through the hold-to-breakeven trap, why it resists rational override, and what actually works to break it.

The Mechanics of the Trap

The trap has four components:

  1. A reference point. Typically the employee’s grant-date FMV, a recent high, or the price at which they first saw the position vest. The reference point becomes the mental “breakeven” below which selling feels like a loss.

  2. A current price below the reference point. The gap between current price and reference point feels like an unrealized loss.

  3. An implicit expectation that the stock will return to the reference point. Usually unsupported by any specific thesis, but psychologically compelling.

  4. A refusal to sell at the current price. Justified as “waiting for recovery,” but operationally identical to “not willing to take a loss.”

The trap is reinforced by the tax code’s asymmetric treatment of losses. A realized capital loss offsets $3,000 of ordinary income per year under §1211, with unlimited carryforward. A realized capital loss can offset unlimited capital gains in the same year. But the employee who has no offsetting gains mentally categorizes the loss as “wasted” when in fact it reduces future tax when gains eventually occur.

Why the Reference Point Is Usually Wrong

The reference point in a concentrated RSU position is typically the vest-date FMV. The vest date FMV was fully taxed as ordinary income on the W-2. The basis for capital-gain purposes is the vest-date FMV. Selling at vest-date FMV produces zero capital gain or loss. Selling below vest-date FMV produces a capital loss equal to the gap, which is economically real but usable against future gains.

For an employee who has held shares for 18 months after vest, the reference point is the vest-date FMV of $180. If the stock falls to $135, the capital loss on sale is $45 per share. On 5,000 shares, that’s $225,000 of capital loss. If the employee also has $225,000 of capital gains elsewhere in the portfolio (from prior RSU vests or other investments), the loss offsets the gain at a 23.8% federal rate plus state. Savings: $65,000 to $90,000 of tax.

Tax-loss harvesting is real and quantifiable. The loss aversion that prevents it is behavioral, not financial.

The “It Will Come Back” Fallacy

Employees routinely justify holding with some version of “the stock will come back.” Without a specific, well-reasoned thesis, this is wishful thinking.

Empirically, a meaningful fraction of tech stocks that decline 30% or more do not fully recover within 3-5 years. A 2024 analysis of 200 post-IPO tech stocks from 2015-2020 showed that of stocks experiencing 40%+ drawdowns, approximately 38% had not recovered to pre-drawdown highs within 36 months. Twenty-two percent never recovered.

The employee holding Meta from $380 in September 2021 to $88 in November 2022 would have needed to hold through a 77% drawdown. Meta did recover to $380 by February 2024. But Meta was a mega-cap with multiple product moats and a reflexive CEO. Not every tech stock has those attributes.

Peloton, Zoom, DocuSign, Beyond Meat, Coinbase, Shopify, Carvana, Spotify: each had 50%+ drawdowns from 2021 peaks. Most had not recovered by early 2026. An employee who held through 2022-2025 on the assumption that “tech comes back” lost years of diversification opportunity.

The selection bias in recovery narratives: the stocks that come back are the ones you remember. The stocks that don’t come back are the ones you stop thinking about.

The Opportunity Cost the Employee Doesn’t See

The opportunity cost of holding a concentrated position waiting for recovery is the return on the diversified portfolio the employee doesn’t hold.

Scenario: $2M position in employer stock at $135, reference point $180. The employee waits for recovery. Over three years, the stock grows 4% annually to $152, a 26% gain from current but still 16% below the reference point. The employee still refuses to sell because they haven’t “gotten back to breakeven.”

Meanwhile, the S&P 500 over the same three years returned 11% annualized. A diversified alternative starting at $2M would have grown to $2.73M, a $730K gain. The concentrated position grew to $2.25M, a $250K gain. The behavior-driven opportunity cost: $480K over three years on a single $2M position.

Over a career, concentrated-position loss aversion costs tech employees roughly 2-4% annualized on their concentrated balance. For a $5M concentrated position, that’s $100K-$200K per year of expected value, compounding.

The Grant Date Is the Wrong Reference Point

Loss aversion anchors on whichever reference point is most available. Three common reference points:

  1. The grant-date FMV: What the stock was worth when granted. For a pre-IPO employee, this might be $15. For a post-IPO employee, $180. The reference point determines the perceived “gain” on the position.

  2. The vesting-date FMV: What the stock was worth when it vested. The tax-basis anchor. Usually the rational reference for tax-loss harvesting decisions.

  3. The recent high: The highest price the employee has seen. Psychologically sticky. A stock at $140 with a recent high of $220 “feels like” a loss position even if the vest-date FMV was $120.

Different reference points lead to different decisions. A sensible decision frame uses the current price and forward-looking diversification as the reference, not the grant-date FMV or the recent high. The forward-looking frame: “Given that I have $X in this stock at today’s price, what allocation would I prefer if I could start from scratch?” If the answer is “much less in this stock,” sell. The past is irrelevant.

What Actually Breaks the Trap

  1. Pre-committed selling schedules. A 10b5-1 plan that sells 25% of every vest automatically removes the loss-aversion decision. The plan doesn’t care about the reference point.

  2. Tax-loss harvesting discipline. Schedule a quarterly review of concentrated positions. If the position is below basis, harvest the loss. The behavioral trick: frame the sale as “capturing tax value” rather than “taking a loss.”

  3. Immediate rebuy into a diversified position. Sell the concentrated stock, immediately buy a diversified index ETF. The dollar value of wealth does not change at the moment of the swap. The concentration risk drops immediately. This reduces the sensation of “losing” because the money doesn’t disappear; it just changes form.

  4. Hedging before sell. A protective put at 10% below current locks in a floor. The employee can hold the position “waiting for recovery” with downside bounded. The behavioral comfort comes from the hedge; the financial comfort comes from not accepting tail risk.

  5. Third-party accountability. A family-office advisor, financial planner, or spouse reviews the concentrated position quarterly and signs off on any hold decisions. The external check breaks the purely internal debate.

Frequently Asked

If I realize a loss, can I buy back the same stock immediately? Not under the wash-sale rule in IRC §1091. A substantially identical security purchased within 30 days before or after the sale triggers wash-sale treatment and disallows the loss. Buy a similar-but-not-identical position (a different tech ETF, a sector fund) to maintain exposure during the 31-day window.

Does the wash-sale rule apply to employer stock if I receive RSU vests during the 61-day window? Yes. A vest during the wash-sale window is a “purchase” for §1091 purposes. Plan around vesting dates when harvesting losses.

What if I have no capital gains to offset? The loss carries forward indefinitely under §1212. It is not wasted. You can use up to $3,000 against ordinary income each year and bank the rest.

Is it better to hold if I think the stock is undervalued? Only if you have a differentiated view. “The company is great” is not a view. “I have material inside information suggesting undervaluation” is a view, but if you act on it, you may have a Rule 10b5-1 problem.

Does loss aversion affect gain positions too? Yes, inversely. Employees with large gains in concentrated positions often refuse to sell because selling triggers gain recognition. This is a different bias (loss-aversion-on-taxes) with similar diversification consequences.

HB
Reviewed by
Helena Borgstrom Pemberton · PhD Behavioral Economics
Behavioral Finance Advisor · Booth School of Business, University of Chicago

Behavioral economist who runs the decision-process coaching for concentrated-stock clients inside a wealth practice. Reviews VestedGrant's behavioral finance content.

Last reviewed April 21, 2026
Free match · no obligation

Find a fiduciary advisor who understands equity compensation

Short form. We match you with up to three fee-only advisors who routinely work with RSUs, ISOs, and pre-IPO equity.

Free · advisors pay us · how we stay independent
Related reading